A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation
Robert B. Jenkins(Mayo Clinic in Florida), Yuanyuan Xiao(University of California, San Francisco), Hugues Sicotte(Mayo Clinic), Paul A. Decker(Mayo Clinic), Thomas M. Kollmeyer(Mayo Clinic), Helen M. Hansen(Neurological Surgery), Matthew Kosel(Mayo Clinic), Shichun Zheng(University of California, San Francisco), Kyle M. Walsh(Neurological Surgery), Terri Rice(Neurological Surgery), Paige M. Bracci(University of California, San Francisco), Lucie McCoy(University of California, San Francisco), Ivan Smirnov(University of California, San Francisco), Joseph S. Patoka(University of California, San Francisco), George Hsuang(Neurological Surgery), Joe Wiemels(University of California, San Francisco), Tarık Tihan(University of California, San Francisco), Alexander R. Pico(Gladstone Institutes), Michael D. Prados(University of California, San Francisco), Susan M. Chang(University of California, San Francisco), Mitchel S. Berger(University of California, San Francisco), Alissa Caron(Mayo Clinic), Stephanie Fink(Mayo Clinic), Chandralekha Halder(Mayo Clinic), Amanda L. Rynearson(Mayo Clinic), Brooke L. Fridley(Mayo Clinic), Jan C. Buckner(Mayo Clinic), Brian Patrick O’Neill(Mayo Clinic), Caterina Giannini(Mayo Clinic), Daniel H. Lachance(Mayo Clinic), John K. Wiencke(Neurological Surgery), Jeanette E. Eckel‐Passow(Mayo Clinic), Margaret Wrensch(University of California, San Francisco)
Cited by 143
Abstract
Related Papers
No related papers found
Powered by citation graph analysis